Research study · Frontiers in Pharmacology · 2026
Real-world quality of life and sleep outcomes in patients treated with THC- and CBD-rich Cannabis oil: a cross-sectional study
Verified on PubMed Clinical Evidence Analysis
A 2026 observational study in Frontiers in Pharmacology tested thc in sleep. The results were positive, but they cannot prove the oil caused the improvement. This study shows that people using this supervised cannabis oil were generally happy with their sleep and quality of life at one point in time, but it cannot show the.
In plain language
Study overview
This study looked at 71 people, mostly women of many ages, who were taking a cannabis oil containing both THC and CBD under the supervision of doctors in Brazil. Each person filled out an online form about their overall quality of life and how well they slept.
Findings
The results were positive, but they cannot prove the oil caused the improvement. Most people described their quality of life and sleep as good, and those who had used the oil longer or at stronger strengths tended to report somewhat better results.
Explore Dr. Caplan's interactive tool detailing cytochrome P450 pathways, clinical titration intervals, and physician surveillance rules.
The deeper readScientific analysis
The endocannabinoid system plays an important role in the modulation of pain, mood, sleep, and subjective wellbeing. Despite the growing clinical use of medicinal Cannabis, real-world data simultaneously evaluating quality of life and sleep-related outcomes in heterogeneous clinical populations remain limited. This study aimed to assess quality of life and sleep satisfaction in patients using medical Cannabis oil under supervised clinical follow-up. This cross-sectional observational study included patients treated with full-spectrum medical Cannabis oil rich in tetrahydrocannabinol (THC) and cannabidiol (CBD) in a real-world clinical setting. Quality of life was assessed using the World Health Organization Quality of Life–BREF (WHOQOL-BREF), and sleep quality was evaluated using the Pittsburgh Sleep Quality Index (PSQI). Sociodemographic, clinical, and treatment-related data were collected via an electronic questionnaire. Nonparametric analyses, Spearman correlation, and ordinal logistic regression models were performed. Seventy-one participants were included, predominantly female, with diverse clinical conditions. Participants reported generally favorable perceptions regarding quality of life and sleep satisfaction, with median scores concentrated in the higher response categories. Positive correlations were observed between the psychological domains of quality of life and sleep satisfaction. Higher Cannabis oil concentrations and longer treatment duration were associated with higher odds of better outcomes. In a real-world clinical context, supervised use of full-spectrum medical Cannabis oil was associated with favorable patient-reported perceptions of quality of life and sleep, consistent with perceived effectiveness. These findings highlight the need for longitudinal studies with pre-treatment baseline assessment.
The paper
Citation
Figueiredo JFLM, de Almeida Soares C, de Oliveira DA, Cassiano FR, Sacramento VM, de Melo-Júnior AF, et al. Real-world quality of life and sleep outcomes in patients treated with THC- and CBD-rich Cannabis oil: a cross-sectional study. Frontiers in Pharmacology (2026). PubMed 42558508 · DOI
Limitations the authors noted
Cross-sectional design with no pre-treatment baseline, precluding causal inference and effect magnitude estimation. Low response rate (71/689; 10.3%) with substantial potential for selection and response bias. Self-reported outcomes subject to expectation, memory, interpretation and social desirability biases. Small exploratory ordinal regression models (n = 71) with sparse categories and quasi-complete separation producing unstable estimates. Possible reverse causality and survivorship bias in association between longer treatment duration and better outcomes. Adherence not monitored, no biological verification of cannabinoid exposure, prior Cannabis use not systematically assessed. Heterogeneous clinical and age population (children to elderly) analyzed jointly; multiple responses on some items handled by retaining highest score, which may introduce upward bias. Industry-affiliated prod
In practice
Why this matters
This study shows that people using this supervised cannabis oil were generally happy with their sleep and quality of life at one point in time, but it cannot show the oil caused those feelings, since there was no starting measurement and only about one in ten invited people answered. It leaves open whether the results would hold for other strengths, other forms of cannabis, other age groups, or over a longer period, and it should be read as a reason for better-designed studies rather than as evidence that the oil works.
Frequently asked questions
Clinical Questions & Answers
What were the primary clinical findings regarding Cannabis and Insomnia?
The results were positive, but they cannot prove the oil caused the improvement. Most people described their quality of life and sleep as good, and those who had used the oil longer or at stronger strengths tended to report somewhat better results.
What study limitations or clinical safeguards should patients keep in mind?
Cross-sectional design with no pre-treatment baseline, precluding causal inference and effect magnitude estimation. Low response rate (71/689; 10.3%) with substantial potential for selection and response bias. Self-reported outcomes subject to expectation, memory, interpretation and social...
Browse related research
Condition: Insomnia Condition: Sleep Topic: Cannabis Topic: CBD Topic: THC
Related on CED Clinic
Back to Daily Research and Patient Questions
Reviewed by Dr. Caplan on November 3, 2026.
This page is general education about a published study. It is not medical advice and does not create a doctor-patient relationship. For care specific to you, book a consultation.